James Martin

Director and Chairman of the Board of Directors

Chairman Board Member CEO CFO

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2023	Cocrystal Pharma, Inc. (COCP)	Co-Chief Executive Officer and Chief Financial Officer	$394,821	$165,000	—	$67,380	—	—	$627,201
2022	Cocrystal Pharma, Inc. (COCP)	Co-Chief Executive Officer and Chief Financial Officer	$371,384	$150,000	—	$100,204	—	—	$621,588
2021	Cocrystal Pharma, Inc. (COCP)	Co-Chief Executive Officer and Chief Financial Officer	$332,500	$100,000	—	$232,500	—	—	$665,000
2020	Cocrystal Pharma, Inc. (COCP)	Co-Interim Chief Executive Officer and Chief Financial Officer	$281,000	$50,000	—	$161,000	—	—	$492,000
2019	Cocrystal Pharma, Inc. (COCP)	Chief Financial Officer	$231,000	—	—	—	—	—	$231,000
2018	Cocrystal Pharma, Inc. (COCP)	Chief Financial Officer	$230,836	—	—	$316,050	—	—	$549,866

Executive changes

Appointed Director at PetVivo Holdings, Inc. (PETV)
2022-10-14
Resigned director at SAB Biotherapeutics, Inc. (SABS)
2021-10-22

Earnings-call appearances

No earnings-call appearances recorded yet.